CLINICAL_TRIALS
trial_result
· 2015-01-14
Clinical Trial Update: Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer [Phase 2]
Summary
Phase 2 safety and toxicity study of sorafenib in patients with renal cell carcinoma completed; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Carcinoma, Renal Cell, Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-01-14